Seeking Alpha

Shares in partners Alkermes (ALKS) and Amylin Pharmaceuticals (AMLN) will resume trading at 4:15...

Shares in partners Alkermes (ALKS) and Amylin Pharmaceuticals (AMLN) will resume trading at 4:15 p.m., after a halt this afternoon tied to the FDA's approval of their Bydureon weekly diabetes treatment. Updated 4:16 p.m.: ALKS +3.6% AH; AMLN +14.8% AH. Now for the tough part.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs